Target Price | $173.81 |
Price | $158.02 |
Potential | 9.99% |
Number of Estimates | 21 |
21 Analysts have issued a price target Procter & Gamble 2026 . The average Procter & Gamble target price is $173.81. This is 9.99% higher than the current stock price. The highest price target is $186.00 17.71% , the lowest is $157.00 0.65% . | |
A rating was issued by 26 analysts: 17 Analysts recommend Procter & Gamble to buy, 8 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Procter & Gamble stock has an average upside potential 2026 of 9.99% . Most analysts recommend the Procter & Gamble stock at Purchase. |
20 Analysts have issued a sales forecast Procter & Gamble 2025 . The average Procter & Gamble sales estimate is $84.3b . This is 0.39% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $85.8b 2.19% , the lowest is $83.7b 0.26% .
This results in the following potential growth metrics:
2024 | $84.0b | 2.48% |
---|---|---|
2025 | $84.3b | 0.26% |
2026 | $86.6b | 2.77% |
2027 | $89.9b | 3.77% |
2028 | $93.2b | 3.75% |
17 Analysts have issued an Procter & Gamble EBITDA forecast 2025. The average Procter & Gamble EBITDA estimate is $23.3b . This is 3.52% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $24.3b 7.80% , the lowest is $22.5b 0.29% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $23.1b | 9.60% |
---|---|---|
2025 | $23.3b | 0.94% |
2026 | $24.3b | 4.06% |
2027 | $25.6b | 5.59% |
2028 | $26.3b | 2.60% |
2024 | 27.48% | 6.95% |
---|---|---|
2025 | 27.67% | 0.69% |
2026 | 28.01% | 1.23% |
2027 | 28.51% | 1.79% |
2028 | 28.19% | 1.12% |
11 Procter & Gamble Analysts have issued a net profit forecast 2025. The average Procter & Gamble net profit estimate is $15.5b . This is 5.01% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $16.3b 10.32% , the lowest is $15.1b 1.90% .
This results in the following potential growth metrics and future Net Margins:
2024 | $14.1b | 2.03% |
---|---|---|
2025 | $15.5b | 9.89% |
2026 | $16.4b | 5.84% |
2027 | $17.6b | 7.10% |
2028 | $18.3b | 4.09% |
2024 | 16.79% | 0.43% |
---|---|---|
2025 | 18.41% | 9.62% |
2026 | 18.96% | 2.99% |
2027 | 19.57% | 3.22% |
2028 | 19.63% | 0.31% |
11 Analysts have issued a Procter & Gamble forecast for earnings per share. The average Procter & Gamble EPS is $6.62 . This is 5.08% higher than earnings per share in the financial year 2024. The highest EPS forecast is $6.95 10.32% , the lowest is $6.42 1.90% .
This results in the following potential growth metrics and future valuations:
2024 | $6.02 | 2.03% |
---|---|---|
2025 | $6.62 | 9.97% |
2026 | $7.00 | 5.74% |
2027 | $7.50 | 7.14% |
2028 | $7.81 | 4.13% |
Current | 25.10 | 7.99% |
---|---|---|
2025 | 23.89 | 4.82% |
2026 | 22.57 | 5.53% |
2027 | 21.07 | 6.65% |
2028 | 20.24 | 3.94% |
Based on analysts' sales estimates for 2025, the Procter & Gamble stock is valued at an EV/Sales of 4.71 and an P/S ratio of 4.40 .
This results in the following potential growth metrics and future valuations:
Current | 4.73 | 5.40% |
---|---|---|
2025 | 4.71 | 0.49% |
2026 | 4.58 | 2.70% |
2027 | 4.41 | 3.63% |
2028 | 4.25 | 3.61% |
Current | 4.41 | 5.77% |
---|---|---|
2025 | 4.40 | 0.39% |
2026 | 4.28 | 2.70% |
2027 | 4.12 | 3.63% |
2028 | 3.97 | 3.62% |
Procter & Gamble...
Analyst | Rating | Action | Date |
---|---|---|---|
Piper Sandler |
Neutral
➜
Neutral
|
Unchanged | May 05 2025 |
B of A Securities |
Buy
➜
Buy
|
Unchanged | Apr 25 2025 |
Raymond James |
Outperform
➜
Outperform
|
Unchanged | Apr 25 2025 |
RBC Capital |
Sector Perform
➜
Outperform
|
Upgrade | Apr 25 2025 |
Citigroup |
Buy
➜
Buy
|
Unchanged | Apr 25 2025 |
Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Apr 25 2025 |
Truist Securities |
Buy
➜
Buy
|
Unchanged | Apr 25 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Piper Sandler:
Neutral
➜
Neutral
|
May 05 2025 |
Unchanged
B of A Securities:
Buy
➜
Buy
|
Apr 25 2025 |
Unchanged
Raymond James:
Outperform
➜
Outperform
|
Apr 25 2025 |
Upgrade
RBC Capital:
Sector Perform
➜
Outperform
|
Apr 25 2025 |
Unchanged
Citigroup:
Buy
➜
Buy
|
Apr 25 2025 |
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Apr 25 2025 |
Unchanged
Truist Securities:
Buy
➜
Buy
|
Apr 25 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.